Advertisement
About 7.9 percent of U.S. adults reported ever use of electronic vapor products shaped like universal serial bus flash drives in 2018

Few U.S. Adults Use USB-Shaped Electronic Vapor Products

0
7.9 percent report ever use of USB-shaped EVPs in 2018; nicotine delivery, friend/family use drive use
From 2004 to 2016

Out-of-Pocket Costs for Neurologic Meds Have Increased

0
Fastest rise in monthly out-of-pocket expenses was seen for multiple sclerosis medications
Higher prepregnancy habitual folate intake from supplements is associated with a lower risk for gestational diabetes mellitus

Prepregnancy Folate Intake Linked to Reduced Risk for GDM

0
Folate intake before pregnancy tied to 22 percent reduction in developing gestational diabetes
Balovaptan

New Drugs May Influence Social Behaviors in Those With Autism

0
Drugs modulating the vasopressin pathway explored as agents to modify social behaviors in autism
Drug overdose deaths involving cocaine and psychostimulants accounted for 19.8 and 14.7 percent

Cocaine-, Psychostimulant-Involved Death Rates Increasing

0
Synthetic opioids driving increases in cocaine-involved deaths, less so in psychostimulant-involved deaths

April 2019 Briefing – Pharmacy

0
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for April 2019. This roundup includes the latest...
Community-dwelling patients with Alzheimer disease experience a lower risk for fractures

Thiazide Use May Lower Fracture Risk in Patients With Alzheimer Disease

0
Longer thiazide use tied to decreased risk for low-energy fractures, hip fractures in Alzheimer disease
For patients with Dravet syndrome and drug-resistant seizures

AAN: Cannabidiol Tied to Drop in Seizures in Dravet Syndrome

0
Percentage reduction in convulsive seizures higher for cannabidiol 10 and 20 mg/kg/day versus placebo
Mavyret (glecaprevir and pibrentasvir) tablets are now approved to treat all six genotypes of hepatitis C virus in children ages 12 to 17 years

FDA Approves Mavyret for Children, Adolescents With Hep C

0
Drug approved for treatment of all six genotypes of hepatitis C virus in children ages 12 to 17
The U.S. Food and Drug Administration is requiring a new boxed warning on sleep medications such as Ambien

FDA Puts Tough Warning Label on Ambien, Lunesta, Other Sleep Aids

0
Move spurred by 66 cases of 'complex sleep behaviors' after taking the insomnia medications